PPD Sales & US ValuationGiven VMD is on track to do about $1 (Canadian) in EBITDA without additional sales of $21 million US ($29 million Canadian) in 2020, the valuation using a 14x multiple puts VMD at $14 excluding the additional sales. We know what the additional product sales were up to the end of April and VieMed just started getting into selling PPD in bulk. The US market is noticing VMD and clearly some players are moving in. I don't think the run is over and any updated guidance on additional sales sometime in June would move the sp even higher. Note: I believe a 14 x multiple on a US stock with this type of growth is on the low side. Time will tell, but the upside momentum continues ... $1 jump is a significant indicator.